Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic kras and impairs senescence in premalignant lesions

Catherine Carrire, A. Jesse Gore, Alixanna M. Norris, Jason R. Gunn, Alison L. Young, Daniel S. Longnecker, Murray Korc

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background & Aims: Rb1 encodes a cell-cycle regulator that is functionally disrupted in most human cancers. Pancreatic ductal adenocarcinomas (PDACs) have a high frequency of mutations in KRAS and INK4A/CDKN2A that might allow cells to bypass the regulatory actions of retinoblastoma (RB). To determine the role of loss of RB function in PDAC progression, we investigated the effects of Rb disruption during pancreatic malignant transformation initiated by oncogenic Kras. Methods: We generated mice with pancreas-specific disruption of Rb, in the absence or presence of oncogenic Kras, to examine the role of RB in pancreatic carcinogenesis. Results: In the presence of oncogenic Kras, loss of Rb from the pancreatic epithelium accelerated formation of pancreatic intraepithelial neoplasia (PanIN), increased the frequency of cystic neoplasms, and promoted rapid progression toward PDAC. Early stage cancers were characterized by acute pancreatic inflammation, associated with up-regulation of proinflammatory cytokines within the pancreas. Despite the presence of markers associated with oncogene-induced senescence, low-grade PanIN were highly proliferative and expressed high levels of p53. Pancreatic cancer cell lines derived from these mice expressed high levels of cytokines, and transcriptional activity of p53 was impaired. Conclusions: Rb encodes a tumor suppressor that attenuates progression of oncogenic Kras-induced carcinogenesis in the pancreas by mediating the senescence response and promoting activity of the tumor suppressor p53.

Original languageEnglish (US)
Pages (from-to)1091-1101
Number of pages11
JournalGastroenterology
Volume141
Issue number3
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Carcinogenesis
Retinoblastoma
Neoplasms
Pancreas
Adenocarcinoma
Cytokines
Mutation Rate
Pancreatic Neoplasms
Oncogenes
Cell Cycle
Up-Regulation
Epithelium
Inflammation
Cell Line

Keywords

  • Chemokine
  • Proliferation
  • Signaling
  • Transformation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Carrire, C., Gore, A. J., Norris, A. M., Gunn, J. R., Young, A. L., Longnecker, D. S., & Korc, M. (2011). Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic kras and impairs senescence in premalignant lesions. Gastroenterology, 141(3), 1091-1101. https://doi.org/10.1053/j.gastro.2011.05.041

Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic kras and impairs senescence in premalignant lesions. / Carrire, Catherine; Gore, A. Jesse; Norris, Alixanna M.; Gunn, Jason R.; Young, Alison L.; Longnecker, Daniel S.; Korc, Murray.

In: Gastroenterology, Vol. 141, No. 3, 09.2011, p. 1091-1101.

Research output: Contribution to journalArticle

Carrire, C, Gore, AJ, Norris, AM, Gunn, JR, Young, AL, Longnecker, DS & Korc, M 2011, 'Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic kras and impairs senescence in premalignant lesions', Gastroenterology, vol. 141, no. 3, pp. 1091-1101. https://doi.org/10.1053/j.gastro.2011.05.041
Carrire, Catherine ; Gore, A. Jesse ; Norris, Alixanna M. ; Gunn, Jason R. ; Young, Alison L. ; Longnecker, Daniel S. ; Korc, Murray. / Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic kras and impairs senescence in premalignant lesions. In: Gastroenterology. 2011 ; Vol. 141, No. 3. pp. 1091-1101.
@article{8c24bf4b8bf245dcac954ae93355c6dc,
title = "Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic kras and impairs senescence in premalignant lesions",
abstract = "Background & Aims: Rb1 encodes a cell-cycle regulator that is functionally disrupted in most human cancers. Pancreatic ductal adenocarcinomas (PDACs) have a high frequency of mutations in KRAS and INK4A/CDKN2A that might allow cells to bypass the regulatory actions of retinoblastoma (RB). To determine the role of loss of RB function in PDAC progression, we investigated the effects of Rb disruption during pancreatic malignant transformation initiated by oncogenic Kras. Methods: We generated mice with pancreas-specific disruption of Rb, in the absence or presence of oncogenic Kras, to examine the role of RB in pancreatic carcinogenesis. Results: In the presence of oncogenic Kras, loss of Rb from the pancreatic epithelium accelerated formation of pancreatic intraepithelial neoplasia (PanIN), increased the frequency of cystic neoplasms, and promoted rapid progression toward PDAC. Early stage cancers were characterized by acute pancreatic inflammation, associated with up-regulation of proinflammatory cytokines within the pancreas. Despite the presence of markers associated with oncogene-induced senescence, low-grade PanIN were highly proliferative and expressed high levels of p53. Pancreatic cancer cell lines derived from these mice expressed high levels of cytokines, and transcriptional activity of p53 was impaired. Conclusions: Rb encodes a tumor suppressor that attenuates progression of oncogenic Kras-induced carcinogenesis in the pancreas by mediating the senescence response and promoting activity of the tumor suppressor p53.",
keywords = "Chemokine, Proliferation, Signaling, Transformation",
author = "Catherine Carrire and Gore, {A. Jesse} and Norris, {Alixanna M.} and Gunn, {Jason R.} and Young, {Alison L.} and Longnecker, {Daniel S.} and Murray Korc",
year = "2011",
month = "9",
doi = "10.1053/j.gastro.2011.05.041",
language = "English (US)",
volume = "141",
pages = "1091--1101",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic kras and impairs senescence in premalignant lesions

AU - Carrire, Catherine

AU - Gore, A. Jesse

AU - Norris, Alixanna M.

AU - Gunn, Jason R.

AU - Young, Alison L.

AU - Longnecker, Daniel S.

AU - Korc, Murray

PY - 2011/9

Y1 - 2011/9

N2 - Background & Aims: Rb1 encodes a cell-cycle regulator that is functionally disrupted in most human cancers. Pancreatic ductal adenocarcinomas (PDACs) have a high frequency of mutations in KRAS and INK4A/CDKN2A that might allow cells to bypass the regulatory actions of retinoblastoma (RB). To determine the role of loss of RB function in PDAC progression, we investigated the effects of Rb disruption during pancreatic malignant transformation initiated by oncogenic Kras. Methods: We generated mice with pancreas-specific disruption of Rb, in the absence or presence of oncogenic Kras, to examine the role of RB in pancreatic carcinogenesis. Results: In the presence of oncogenic Kras, loss of Rb from the pancreatic epithelium accelerated formation of pancreatic intraepithelial neoplasia (PanIN), increased the frequency of cystic neoplasms, and promoted rapid progression toward PDAC. Early stage cancers were characterized by acute pancreatic inflammation, associated with up-regulation of proinflammatory cytokines within the pancreas. Despite the presence of markers associated with oncogene-induced senescence, low-grade PanIN were highly proliferative and expressed high levels of p53. Pancreatic cancer cell lines derived from these mice expressed high levels of cytokines, and transcriptional activity of p53 was impaired. Conclusions: Rb encodes a tumor suppressor that attenuates progression of oncogenic Kras-induced carcinogenesis in the pancreas by mediating the senescence response and promoting activity of the tumor suppressor p53.

AB - Background & Aims: Rb1 encodes a cell-cycle regulator that is functionally disrupted in most human cancers. Pancreatic ductal adenocarcinomas (PDACs) have a high frequency of mutations in KRAS and INK4A/CDKN2A that might allow cells to bypass the regulatory actions of retinoblastoma (RB). To determine the role of loss of RB function in PDAC progression, we investigated the effects of Rb disruption during pancreatic malignant transformation initiated by oncogenic Kras. Methods: We generated mice with pancreas-specific disruption of Rb, in the absence or presence of oncogenic Kras, to examine the role of RB in pancreatic carcinogenesis. Results: In the presence of oncogenic Kras, loss of Rb from the pancreatic epithelium accelerated formation of pancreatic intraepithelial neoplasia (PanIN), increased the frequency of cystic neoplasms, and promoted rapid progression toward PDAC. Early stage cancers were characterized by acute pancreatic inflammation, associated with up-regulation of proinflammatory cytokines within the pancreas. Despite the presence of markers associated with oncogene-induced senescence, low-grade PanIN were highly proliferative and expressed high levels of p53. Pancreatic cancer cell lines derived from these mice expressed high levels of cytokines, and transcriptional activity of p53 was impaired. Conclusions: Rb encodes a tumor suppressor that attenuates progression of oncogenic Kras-induced carcinogenesis in the pancreas by mediating the senescence response and promoting activity of the tumor suppressor p53.

KW - Chemokine

KW - Proliferation

KW - Signaling

KW - Transformation

UR - http://www.scopus.com/inward/record.url?scp=80052127297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052127297&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2011.05.041

DO - 10.1053/j.gastro.2011.05.041

M3 - Article

C2 - 21699781

AN - SCOPUS:80052127297

VL - 141

SP - 1091

EP - 1101

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 3

ER -